News und Analysen
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
Key Points
- Interested in Bruker Corporation? Here are five stocks we like better.
- Order momentum is improving across Bruker’s business, with semiconductor metrology, overseas
BioAge Labs Eyes Key BGE-102 Readouts in Heart Risk and Diabetic Eye Disease
Key Points
- Interested in BioAge Labs, Inc.? Here are five stocks we like better.
- BioAge Labs said its lead drug BGE-102 is on track for near-term data in two areas: a Phase 2 cardiovascular
Gerresheimer Aktie: Goldman erhöht auf 20,03 Prozent
Goldman Sachs baut bei Gerresheimer weiter auf. Die US-Investmentbank hält nun 20,03 Prozent der…
Der Beitrag Gerresheimer Aktie: Goldman erhöht auf 20,03 Prozent erschien zuerst auf kapitalmarktexp
Black Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA Path
Key Points
- Interested in Black Diamond Therapeutics, Inc.? Here are five stocks we like better.
- Silevertinib showed encouraging Phase 2 lung cancer data, including a 60% objective response
Bayer Aktie: 7,25-Mrd.-Vergleich am 9. Juli
35,95 Euro – das ist der Stand der Dinge bei Bayer zum Ende der…
Der Beitrag Bayer Aktie: 7,25-Mrd.-Vergleich am 9. Juli erschien zuerst auf kapitalmarktexperten.de.
Quelle kapitalmarktexperten.de
BioCryst Pharmaceuticals Backs ORLADEYO Outlook as Navenibart Trial Advances
Key Points
- Interested in BioCryst Pharmaceuticals, Inc.? Here are five stocks we like better.
- BioCryst reaffirmed full-year ORLADEYO revenue guidance of $625 million to $645 million and
Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline
Key Points
- Interested in Axsome Therapeutics, Inc.? Here are five stocks we like better.
- Axsome Therapeutics said it is on track to launch Auvelity for Alzheimer’s disease agitation this
Arrowhead Pharmaceuticals Lines Up SHASTA Readout as REDEMPLO Launch Gains Traction
Key Points
- Interested in Arrowhead Pharmaceuticals, Inc.? Here are five stocks we like better.
- SHASTA-3 and SHASTA-4 topline data for plozasiran in severe hypertriglyceridemia remain on track
argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference
Key Points
- Interested in argenex SE? Here are five stocks we like better.
- argenx said its main priorities are revenue growth, profitability and execution as it expands the VYVGART franchise
Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference
Key Points
- Interested in Amgen Inc.? Here are five stocks we like better.
- Amgen highlighted strong first-quarter performance, with revenue up 6% year over year and non-GAAP EPS up 5%
Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment
Key Points
- Interested in Aldeyra Therapeutics, Inc.? Here are five stocks we like better.
- Aldeyra Therapeutics is awaiting near-term FDA feedback on its dry eye drug reproxalap after a third
Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near
Key Points
- Interested in Akebia Therapeutics, Inc.? Here are five stocks we like better.
- Vafseo uptake is improving, with Akebia saying the number of prescribing physicians rose 28% to about
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
Key Points
- Interested in Aclaris Therapeutics, Inc.? Here are five stocks we like better.
- Aclaris Therapeutics is preparing a packed clinical calendar, with data expected in the second half of
Bayer Aktie: FIND-CKD-Daten beim ERA-Kongress am 5. Juni
Während Bayer seit Monaten unter Rechtsrisiken leidet, liefert der Konzern heute ein Gegensignal aus…
Der Beitrag Bayer Aktie: FIND-CKD-Daten beim ERA-Kongress am 5. Juni erschien zuerst auf kapital
Medtronic Bottoms, Healthy Rebound Ahead
Key Points
- Interested in Medtronic PLC? Here are five stocks we like better.
- Medtronic is on track to rebound in the back half of 2026.
- Solid results, cash flow, and dividends point to a shift in
AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam
Key Points
- Interested in AbCellera Biologics Inc.? Here are five stocks we like better.
- AbCellera is pivoting from a partner-driven antibody discovery platform to a proprietary drug
Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?
Key Points
- Interested in Rocket Lab Corporation? Here are five stocks we like better.
- Rocket Lab's 24% pullback from its 52-week high appears to reflect normal consolidation rather than any
S4 Capital Touts AI Gains, Lower Debt at AGM Despite Tough Ad Market
Key Points
- Interested in S4 Capital plc? Here are five stocks we like better.
- Trading remains under pressure from macroeconomic uncertainty and cautious clients, with management citing
Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach
Key Points
- Interested in Ardelyx, Inc.? Here are five stocks we like better.
- Ardelyx said its two commercial products, IBSRELA and XPHOZAH, are on track to generate more than $500 million in
Fresenius Aktie: 36,73 Euro — Insiderkauf am 28. Mai
Ein Insiderkauf allein dreht keinen Trend. Bei Fresenius kommt er aber zur rechten Zeit.…
Der Beitrag Fresenius Aktie: 36,73 Euro — Insiderkauf am 28. Mai erschien zuerst auf kapitalmarktexperten.de
Bayer Aktie: Fall an Richter Chhabria verwiesen
Heute endet in den USA eine entscheidende Frist für Bayer. Bis zum 4. Juni…
Der Beitrag Bayer Aktie: Fall an Richter Chhabria verwiesen erschien zuerst auf kapitalmarktexperten.de.
Quelle kapitalmar
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
Key Points
- Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amphastar reaffirmed its expectation for mid- to high-single-digit revenue growth in 2026, with
ALX Oncology Targets Key Readouts to Advance CD47, EGFR Cancer Drug Programs
Key Points
- Interested in ALX Oncology Holdings Inc.? Here are five stocks we like better.
- ALX Oncology expects key data readouts in the coming months for its lead CD47 drug evorpacept and its
Advanced Energy Industries Sees Semiconductor, Data Center Strength as Margins Climb
Key Points
- Interested in Advanced Energy Industries, Inc.? Here are five stocks we like better.
- Advanced Energy said its semiconductor business is seeing a large pickup in orders, with backlog
Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference
Key Points
- Interested in Adaptive Biotechnologies Corporation? Here are five stocks we like better.
- clonoSEQ, Adaptive Biotechnologies’ flagship MRD test, remains the company’s core growth